Natera(NTRA) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Natera Reports Second Quarter 2025 Financial Results AUSTIN, Texas, August 7, 2025 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today reported its financial results for the second quarter ended June 30, 2025. Recent Financial Highlights "We delivered outstanding results in the second quarter, with record Signatera growth and continued strength across our women's health and organ health product lines," said Steve Chapman, chief executive of ...